Abstract
Sixty-seven pairs of mothers with hepatitis B virus (HBV) surface antigen (HBsAg) and their infants were divided into two study groups to determine the effect of amniocentesis on intrauterine HBV infection. In the first study group (35 pairs), the infant's HBsAg status in cord blood was studied and the results were compared with those obtained in the cord blood from 65 infants born to HBsAg-positive women who did not have an amniocentesis. In the second study group (32 pairs), the HBV status of the infants was studied at the age of three months to five years and compared with the HBV status of 3,454 infants in the National HBV Prevention Program. In the first study group, one sample (2.9%) was weakly positive for HBsAg; while in the first control group, two (3.1%) were positive. In the second study group, three (10%) infants were positive for HBsAg. The failure rates of immunoprophylaxis in the second study and control groups were similar (9.4% vs 11% for HBsAg carrier mothers; 30% vs 14% for HBe antigen-positive carrier mothers). This suggested that genetic amniocentesis did not increase the risk of intrauterine HBV infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bancroft WH, Snitbhan R, Scott RM, Tingpalapong M, Watson WT, Tanticharoenyos P, Karwacki JJ, Srimarut S (1977) Transmission of hepatitis B virus to gibbons by exposure to human saliva containing hepatitis B surface antigen. J Infect Dis 135:79–85
Beasley RP, Hwang LY (1983) Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis 147:185–190
Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. Lancet II:1129–1133
Beasley RP, Hwang LY, Lee GCY, Lan CC, Roan CH, Huang FY, Chen CL (1983a) Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet II:1099–1102
Beasley RP, Hwang LY, Stevens CE, Lin CC, Hsieh FJ, Wang KY, Sun TS, Szmuness W (1983b) Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: final report of a randomized double-blind, placebo-controlled trial. Hepatology 3:135–141
Chen DS, Sung JL (1978) Hepatitis B virus infection and chronic liver disease in Taiwan. Acta Hepato-Gastroenterol 25:423–430
Chen DS, Hsu NHM, Sung JL, Hsu TC, Hsu ST, Kuo YT, Lo KJ, Shih YT, The Hepatitis Steering Committee, The Hepatitis Control Committee (1987) A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 257:2597–2603
Cowchock FS (1976) Use of alpha-fetoprotein in prenatal diagnosis. Clin Obstet Gynecol 19:871–892
Hsu HM, Chen DS, Chuang CH, Lu JCF, Jwo DM, Lee CC, Lu HC, Cheng SH, Wang YF, Chen Wang C, Lo KJ, Shih CJ, Sung JL, The Hepatitis Control Committee, The Hepatitis Steering Committee (1988) Efficacy of a mass hepatitis B vaccination program in Taiwan. JAMA 260:2231–2235
Imai M, Yanase Y, Nojiri T, Miyakawa Y, Mayumi M (1979) A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology 76:242–247
Ko TM, Lin KH, Ho MM, Hwang MF, Hwang KC, Hsieh FJ, Yaung CL, Chen DS (1986) Perinatal transmission of hepatitis B virus in the Taoyuan area. J Formosan Med Assoc 85:341–351
Lin HH, Lee TY, Chen DS, Sung JL, Ohto H, Etoh T, Kawana T, Mizuno M (1987) Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 111:877–881
London WT, O'Connell AP (1986) Transplacental transmission of hepatitis B virus. Lancet I:1037–1039
Mennuti MT, Brummond W, Crombleholme WR, Schwarz RH, Arvan DA (1980) Fetal-maternal bleeding associated with genetic amniocentesis. Obstet Gynecol 55:48–54
Neurath AR, Kent SBH, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429–436
Okamoto H, Usuda S, Imai M, Tachibana K, Tanaka E, Kumakura T, Itabashi M, Takai E, Tsuda F, Nakamura T, Miyakawa Y, Mayumi M (1986) Antibody to the receptor for polymerized human serum albumin in acute and persistent infection with hepatitis B virus. Hepatology 6:354–359
Pontisso P, Alberti A, Bortolotti F, Realdi G (1983) Virus-associated receptors for polymerized human serum albumin in acute and in chronic hepatitis B virus infection. Gastroenterology 84:220–226
Stevens CE, Neurath RA, Beasley RP, Szmuness W (1979) HBeAg and anti-HBe detection of radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 3:237–241
Wong VCW, Lee AKY, Ip HMH (1980) Transmission of hepatitis B surface antigen from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol 87:958–965
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ko, T.M., Tseng, L.H., Chang, M.H. et al. Amniocentesis in mothers who are hepatitis B virus carriers does not expose the infant to an increased risk of hepatitis B virus infection. Arch Gynecol Obstet 255, 25–30 (1994). https://doi.org/10.1007/BF02390671
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02390671